VL Surveyor Methodology

The visceral leishmaniasis (VL) Surveyor maps all the relevant registered and published VL clinical trials looking at efficacy of pharmaceuticals, conducted globally to date. Created in 2016, the Surveyor includes data derived from a systematic review (Bush JT, Wasunna M, Alves F, Alvar J, Olliaro PL, Otieno M, et al. (2017) Systematic review of clinical trials assessing the therapeutic efficacy of visceral leishmaniasis treatments: A first step to assess the feasibility of establishing an individual patient data sharing platform. PLoS Negl Trop Dis 11(9): e0005781) conducted in the same year. In addition to the data from this systematic review, the Surveyor is regularly updated with details of newly-registered and published trials.